logo
Select company
Select metric
-18387.4%EBIT Margin
VS
Market
1
Sector
4
Industry
7
History
13
$ 4.81Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information

Ticker

ADVM

Company Name

ADVERUM BIOTECHNOLOGIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADVERUM BIOTECHNOLOGIES INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADVM - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -183.87M-18387.4%$ 1M
3/31/2025$ -153.16M-15315.9%$ 1M
12/31/2024$ -130.93M-13092.7%$ 1M
9/30/2024$ -95.24M-9524.4%$ 1M
6/30/2024$ -100.98M0%$ 0
3/31/2024$ -113.99M0%$ 0
12/31/2023$ -118.24M-3284.53%$ 3.6M
9/30/2023$ -126.11M-3503.14%$ 3.6M
6/30/2023$ -133.36M-3704.42%$ 3.6M
3/31/2023$ -145.61M-4044.78%$ 3.6M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average EBIT % has been -6518.29%.
  • The median EBIT % for ADVERUM BIOTECHNOLOGIES INC during this period was -3603.78%
  • ADVERUM BIOTECHNOLOGIES INC reached its highest EBIT % over the past 5 years at -1625.64%.
  • The lowest EBIT % recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe -18387.4%

ADVERUM BIOTECHNOLOGIES INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
DTIL : PRECISION BIOSCIENCES INC -6097.94%RANI : RANI THERAPEUTICS HOLDINGS INC -2117.08%RNXT : RENOVORX INC -1668.88%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1339.78%PLUR : PLURI INC -1609.96%LSTA : LISATA THERAPEUTICS INC -1858.41%IGC : IGC PHARMA INC -477.92%CLSD : CLEARSIDE BIOMEDICAL INC -2008.71%COEP : COEPTIS THERAPEUTICS HOLDINGS INC -3832.35%RLYB : RALLYBIO CORP -5473.32%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: EBIT [ $ -98.8M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

ADVM - EBIT Margin, Last 5 years

-18387.4%

Minimum

Jun 30, 2025

-1625.64%

Maximum

Mar 31, 2021

-6518.29%

Average

-3603.78%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%